This page contains recent news articles, when available, and an overview of but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Background information on

anges mg files bla for naglazyme  -  Nov 16, 2007
Trading Markets (press release),...(ec) for mps vi mps vi (also known as maroteaux-lamy syndrome). stephen aselage, senior vice president of global commercial development at biomarin,

Biomarin partner AnGes submits enzyme replacement drug for ...  -  Aug 13, 2007
Forbes,2005 and by the European Commission in January 2006. The drug is used to treat Maroteaux-Lamy syndrome, a genetic disease caused by an enzyme deficiency.

BioMarin Partner AnGes Submits BLA For Naglazym To Japanese ...  -  Aug 13, 2007
RTT News,Naglazyme is the first and only enzyme replacement therapy indicated for the treatment of MPS VI, or also known as Maroteaux-Lamy syndrome.

BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry ...  -  Aug 13, 2007
CNNMoney.comMPS VI (also known as Maroteaux-Lamy syndrome) is a debilitating, life-threatening genetic disease caused by a deficiency of the enzyme

New DNA Tests Advance Diagnosis/Early Treatment of Lysosomal ...  -  May 21, 2007
DentalPlans.com,Over the past decade, ERT has become available for Fabry disease, Mucopolysaccharidosis Type VI (MPS VI - Maroteaux-Lamy), and MPS I (Hurler, Hurler-Scheie,

State steps in to help Sophie  -  Apr 17, 2007
Courier Mail,Sophie Nance, of Springfield Lakes, is one of just 13 Australians diagnosed with Maroteaux-Lamy Syndrome, a rare genetic condition caused by a missing

Fighting for life  -  Feb 23, 2007
Courier Mail,At 13-months-old Sophie Nance was diagnosed with the fatal disease Maroteaux-Lamy syndrome, a rare condition caused by the lack of an enzyme that breaks

BioMarin Says Hypertension Treatment Failed in Trial (Update2)  -  Feb 20, 2007
BloombergNalglazyme, an enzyme replacement therapy, treats Maroteaux- Lamy syndrome, a hereditary progressive disease that leads to organ disfunction and severe

Japan's AnGes MG to market US remedy for rare children's disease  -  Jan 21, 2007
Antara,The drug, called Naglazyme, treats Maroteaux-Lamy syndrome (MPS VI), a disease caused by a rare genetic metabolic disorder.

A costly second chance for little Isaac  -  Dec 26, 2006
Globe and Mail,It is that of a preschooler thriving after receiving one of the most expensive drugs in the world -- Naglazyme -- the only treatment for Maroteaux-Lamy

A costly second chance for little Isaac  -  Dec 26, 2006
Globe and Mail,...that of a preschooler thriving after receiving one of the most expensive drugs in the world -- Naglazyme -- the only treatment for Maroteaux-Lamy syndrome, an ...

Health Watch  -  Nov 20, 2006
Organiser,Leukemia (JCML), Krabbe Disease, Juvenile Myelomonocytic Leukemia (JMML), Lesch-Nyhan Syndrome, Lukecyte Adhesion Deficiency, Maroteaux-Lamy Syndrome (MPS-VI ...

Guatemalan girl gets life saver, but family running out of time  -  Nov 14, 2006
Inside Bay Area,She is also one of 1,100 people worldwide suffering from Maroteaux-Lamy Syndrome, an enzymatic disorder that ravages all the major systems of the body. ...

Search the web for more resources on

Web health.mongabay.com

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.